Ricks to smart to waste time on that. Darren is not however and would be dumpy.
Nothing against the lgbqt group, but if they would spend less time there and focused on our future acquisitions, we’d have a brighter future.
We’re behind the industry in cannabinoids. Why spend the extra money and time to create it when it’s found in cannabis. I hope we don’t try to go around obtaining it from cannabis due to the stigma, get out of the 80’s Reagan DARE era. Get some balls Ricks. GW pharma has been on this for 20 years, no way we catch up unless we acquire them. Ha, wel there’s an idea! Look them up and their stock, ripe for the picking and solid pipeline from their r&d. And don’t say synthetic, insys is garbage... tilray and canopy are behind in technology to isolate the appropriate cannabinoids.
Interested to see if we are going to go all in here or just continue dipping our toes in the water.
Come on Ricks, her Darren and Michael on this case pronto!
Nothing against the lgbqt group, but if they would spend less time there and focused on our future acquisitions, we’d have a brighter future.
We’re behind the industry in cannabinoids. Why spend the extra money and time to create it when it’s found in cannabis. I hope we don’t try to go around obtaining it from cannabis due to the stigma, get out of the 80’s Reagan DARE era. Get some balls Ricks. GW pharma has been on this for 20 years, no way we catch up unless we acquire them. Ha, wel there’s an idea! Look them up and their stock, ripe for the picking and solid pipeline from their r&d. And don’t say synthetic, insys is garbage... tilray and canopy are behind in technology to isolate the appropriate cannabinoids.
Interested to see if we are going to go all in here or just continue dipping our toes in the water.
Come on Ricks, her Darren and Michael on this case pronto!
Nothing against the lgbqt group, but if they would spend less time there and focused on our future acquisitions, we’d have a brighter future.
We’re behind the industry in cannabinoids. Why spend the extra money and time to create it when it’s found in cannabis. I hope we don’t try to go around obtaining it from cannabis due to the stigma, get out of the 80’s Reagan DARE era. Get some balls Ricks. GW pharma has been on this for 20 years, no way we catch up unless we acquire them. Ha, wel there’s an idea! Look them up and their stock, ripe for the picking and solid pipeline from their r&d. And don’t say synthetic, insys is garbage... tilray and canopy are behind in technology to isolate the appropriate cannabinoids.
Interested to see if we are going to go all in here or just continue dipping our toes in the water.
Come on Ricks, her Darren and Michael on this case pronto!
In R&D, innovation is a liability to being productive. Do something new, has potential. Other people hear about it. Want to get in on it. Suddenly, you are being asked to train people in your innovative methods... methods you spent a great deal of personal time to develop. Even worse, you are asked to train people who keep failing every method they train on. “Maybe this one will stick! C’mon, be a good team player!” Waste of time, they don’t learn it because they don’t take notes, then blame you to their boss.
Meanwhile, you are so distracted with training untrainable people that someone else takes your method without asking or at least looping you in on it, then applies it to their project, then takes the credit for it.
The culture here punishes innovation. In case nobody else has noticed. When you do something innovative, it increases your workload and devalues your skillset.
